Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation and Depletion (2017 - 2023)

Solid Biosciences (SLDB) has disclosed Depreciation and Depletion for 7 consecutive years, with $587000.0 as the latest value for Q4 2023.

  • Quarterly Depreciation and Depletion rose 8.91% to $587000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2023, up 7.18% year-over-year, with the annual reading at $2.6 million for FY2023, 7.18% up from the prior year.
  • Depreciation and Depletion hit $587000.0 in Q4 2023 for Solid Biosciences, roughly flat from $588000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.3 million in Q2 2020 to a low of $438000.0 in Q3 2022.
  • Historically, Depreciation and Depletion has averaged $734950.0 across 5 years, with a median of $720000.0 in 2021.
  • Biggest five-year swings in Depreciation and Depletion: surged 162.56% in 2019 and later plummeted 46.18% in 2021.
  • Year by year, Depreciation and Depletion stood at $806000.0 in 2019, then dropped by 1.24% to $796000.0 in 2020, then decreased by 4.52% to $760000.0 in 2021, then dropped by 29.08% to $539000.0 in 2022, then grew by 8.91% to $587000.0 in 2023.
  • Business Quant data shows Depreciation and Depletion for SLDB at $587000.0 in Q4 2023, $588000.0 in Q3 2023, and $703000.0 in Q2 2023.